港股海西新药涨超10%

Core Viewpoint - HaiXi New Drug (02637.HK) experienced a significant increase in stock price, rising over 10% to reach a new high of 145.9 HKD, marking an approximate 70% increase from its IPO price of 86.4 HKD [2] Summary by Category - Stock Performance - The stock price of HaiXi New Drug reached 145.9 HKD, representing a rise of 10.87% at the time of reporting [2] - The trading volume was reported at 16.7142 million HKD [2] - Market Reaction - The stock has set a new record high since its listing, indicating strong market interest and investor confidence [2]